These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Supraventricular arrhythmias in children and young adults with implantable cardioverter defibrillators. Love BA; Barrett KS; Alexander ME; Bevilacqua LM; Epstein MR; Triedman JK; Walsh EP; Berul CI J Cardiovasc Electrophysiol; 2001 Oct; 12(10):1097-101. PubMed ID: 11699514 [TBL] [Abstract][Full Text] [Related]
6. Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study. Kolb C; Sturmer M; Sick P; Reif S; Davy JM; Molon G; Schwab JO; Mantovani G; Dan D; Lennerz C; Borri-Brunetto A; Babuty D JACC Heart Fail; 2014 Dec; 2(6):611-9. PubMed ID: 25282033 [TBL] [Abstract][Full Text] [Related]
7. Initial clinical experience with a new arrhythmia detection algorithm in dual chamber implantable cardioverter defibrillators. Theuns D; Klootwijk AP; Kimman GP; Szili-Török T; Roelandt JR; Jordaens L Europace; 2001 Jul; 3(3):181-6. PubMed ID: 11467458 [TBL] [Abstract][Full Text] [Related]
8. Approach to reduction of ventricular arrhythmias and implantable cardioverter-defibrillator therapies in patients with heart failure. Sengupta J; Abdelhadi R Curr Opin Cardiol; 2013 May; 28(3):337-43. PubMed ID: 23549236 [TBL] [Abstract][Full Text] [Related]
9. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study. Powell BD; Saxon LA; Boehmer JP; Day JD; Gilliam FR; Heidenreich PA; Jones PW; Rousseau MJ; Hayes DL J Am Coll Cardiol; 2013 Oct; 62(18):1674-1679. PubMed ID: 23810882 [TBL] [Abstract][Full Text] [Related]
10. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator. Korte T; Köditz H; Niehaus M; Paul T; Tebbenjohanns J Pacing Clin Electrophysiol; 2004 Jul; 27(7):924-32. PubMed ID: 15271011 [TBL] [Abstract][Full Text] [Related]
11. Programming implantable cardioverter-defibrillators in primary prevention: higher or later. Clementy N; Pierre B; Simeon E; Lallemand B; Fauchier L; Babuty D Arch Cardiovasc Dis; 2014 May; 107(5):308-18. PubMed ID: 24834904 [TBL] [Abstract][Full Text] [Related]
12. Expanding the benefits of implantable cardioverter-defibrillator therapy: "is less more"? Jackson LR; Daubert JP; Thomas KL Prog Cardiovasc Dis; 2012; 54(4):372-8. PubMed ID: 22226007 [TBL] [Abstract][Full Text] [Related]
13. Importance of the atrial channel for ventricular arrhythmia therapy in the dual chamber implantable cardioverter defibrillator. Dijkman B; Wellens HJ J Cardiovasc Electrophysiol; 2000 Dec; 11(12):1309-19. PubMed ID: 11196552 [TBL] [Abstract][Full Text] [Related]
14. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation. Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943 [TBL] [Abstract][Full Text] [Related]
15. Role of antiarrhythmic drugs in patients with implantable cardioverter defibrillators. Van Herendael H; Pinter A; Ahmad K; Korley V; Mangat I; Dorian P Europace; 2010 May; 12(5):618-25. PubMed ID: 20304841 [TBL] [Abstract][Full Text] [Related]